Your browser doesn't support javascript.
loading
Safety of a 2-visit cluster schedule of venom immunotherapy in outpatients at risk of life-threatening anaphylaxis.
Sánchez-Machín, I; Moreno, C; González, R; Iglesias-Souto, J; Pérez, E; Matheu, V.
Affiliation
  • Sánchez-Machín I; Allergy Service, Hospital Universitario NS Candelaria, Santa Cruz de Tenerife, Spain.
J Investig Allergol Clin Immunol ; 20(1): 91-2, 2010.
Article in En | MEDLINE | ID: mdl-20232782
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Bee Venoms / Desensitization, Immunologic / Anaphylaxis Type of study: Etiology_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Child / Female / Humans / Male / Middle aged Language: En Journal: J Investig Allergol Clin Immunol Journal subject: ALERGIA E IMUNOLOGIA Year: 2010 Document type: Article Affiliation country: España
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Bee Venoms / Desensitization, Immunologic / Anaphylaxis Type of study: Etiology_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Child / Female / Humans / Male / Middle aged Language: En Journal: J Investig Allergol Clin Immunol Journal subject: ALERGIA E IMUNOLOGIA Year: 2010 Document type: Article Affiliation country: España